Amit Paley CEO- Trevor Project CEO Removed From Position After Staff Outcry. (2024)
You can help us put a stop to online scams before they grow too big and end up ruining thousands of lives. A scam is a scam, doesn’t matter if it’s big or small. Now that this is out of the way, let’s get started with the review.
Amit Paley CEO claims to be the International Rescue Committee’s Entrepreneur in Residence, a global humanitarian organization that delivers help and development in 40 war-torn nations. According to Amit Paley CEO, he formerly worked as CEO of The Trevor Project, the world’s biggest LGBTQ youth suicide prevention and mental health organization. Taking pride in his work Amit Paley CEO claims that under Amit Paley’s direction, The Trevor Project more than tenfold increased the number of adolescents supported, started a global expansion, and built breakthrough technology solutions employing AI and machine learning that were named one of TIME magazine’s top 100 inventions of the year.
Amit Paley CEO asserts that he is a successful CEO, social entrepreneur, activist, and journalist. Amit Paley CEO claims that he has held positions of leadership in both the private and public sectors, and he has counseled Fortune 500 corporations, governments, and non-profit organizations. Amit Paley CEO and his husband live in Brooklyn.
Amit Paley CEO claims that he was also an Associate Partner at McKinsey & Company, where he worked with Fortune 500 firms, governments, and non-profit organizations. According to Amit Paley CEO, he began his career at The Washington Post as a reporter covering a variety of high-profile beats, including serving as a foreign correspondent located in Iraq, where his work was nominated for a Pulitzer Prize, and as a financial investigative journalist.
Amit Paley CEO also claims to be a well-known public speaker who has appeared in The New York Times, USA Today, ABC, NBC, CBS, NPR, and CNN. Amit Paley CEO claims to have taught as an adjunct professor at the City University of New York and has served on the National Suicide Prevention Lifeline Steering Committee, the Executive Committee of the National Action Alliance for Suicide Prevention, the Board of the Center for Public Integrity, and the National Action Alliance for Suicide Prevention.
Amit Paley CEO claims that he has served on the National Suicide Prevention Lifeline Steering Committee, the Executive Committee of the National Action Alliance for Suicide Prevention, the Board of the Center for Public Integrity, and the Graduate Council of The Harvard Crimson. Showing off his achievements further, Amit Paley CEO claims to have received a magna cum laude degree from Harvard College and an MBA from Columbia Business School.
We look at 34 different data points when analyzing and rating online money-earning opportunities. Once the research on these data points is submitted, expert contributors reach out to the company’s customers and associates to get more insight into their operation. Finally, all the collected information is presented in the form of this expert review.
All the data is extracted from publicly available information and the sources are given in the transparency section at the bottom of every report.
These reports are made possible by the collective efforts of contributors like you. If you would like to become a contributor then contact us here.
Amit Paley CEO- Trevor Project (Amit Paley’s company)
The Trevor Project claims to be a non-profit organization based in the United States that was created in 1998. They provide a toll-free telephone number where qualified counselors can provide confidential assistance to lesbian, gay, bisexual, transgender, queer, and questioning (LGBTQ) kids. The project’s stated goals are to provide crisis intervention and suicide prevention services to youth (defined by the organization as those under the age of 25), as well as to provide guidance and resources to parents and educators in order to foster safe, accepting, and inclusive environments for all youth at home, schools, and colleges.
Amit Paley CEO- The Trevor Project Fires CEO Amit Paley Due to Staff Concerns
The Trevor Project’s board of directors has fired CEO Amit Paley, effective immediately, according to a source close to the LGBTQ suicide prevention organization.
On Wednesday, November 2, Amit Paley CEO was fired from his position. According to the source, the decision was motivated by employee dissatisfaction, particularly with regard to the organization’s rapid large-scale growth and the stress it imposed on personnel. The insider revealed that many personnel signed a letter expressing their displeasure with Paley’s dismissal. (According to two further accounts, approximately 200 employees signed this letter.)
Peggy Rajski, co-founder of the Trevor Project, has been named temporary CEO by the board. Gina Muoz, emeritus chair of the Board of Directors, will be her special assistant. Amit Paley CEO’s name has already been removed from the website’s leadership team.
The decision comes only months after Amit Paley CEO’s questionable former work with the opioid manufacturer Purdue was revealed, and after Teen Vogue reported employee dissatisfaction with his leadership and management at the group.
Amit Paley CEO worked as a consultant at McKinsey & Co., where she advised Purdue on how to increase opioid sales. In July, HuffPost and Teen Vogue reported on the work, which was based on papers revealed as part of a countrywide litigation settlement with the pharmaceutical corporation. Several Trevor Project staff members told Teen Vogue that Paley’s previous work was hypocritical considering the objective of the suicide prevention group he most recently managed.
“The Trevor Project is currently facing a period of transition, rethinking how to sustainably grow our 24/7 crisis services to respond to the public health crisis of LGBTQ youth suicide and address the mental health disparities impacting these youth. In 2017, the organization averaged less than 200 inbound crisis contacts per day; in 2022, it’s averaging more than 2,000 crisis contacts per day,” The Trevor Project said in a statement to Teen Vogue on Friday evening.
“Relentless attacks against LGBTQ youth and their families also continue to raise the temperature for our crisis services, advocacy, research, and education work. This intense climate has led to significant stress on our organization, and many members of our staff have raised concerns about workplace well-being, professional development, prioritization performance metrics, and resourcing compensation — particularly as they impact our BIPOC, transgender, nonbinary, and disabled team members. While a comprehensive, independent review of The Trevor Project is being conducted, the Board of Directors elected to make a change in leadership.”
“Peggy Rajski, Founder of The Trevor Project and longtime board member, will serve as interim CEO until a permanent CEO is found.” Gina Muoz, Chair Emeritus, will serve as Special Assistant to the Interim CEO, according to the announcement. “The Trevor Project remains committed to focusing on our core mission and the LGBTQ youth we serve, as well as ensuring The Trevor Project is a safe space for all.”
Amit Paley CEO expressed contrition for his former work in an internal message issued to colleagues after his work for Purdue was first disclosed this summer, and he reiterated these sentiments in an earlier statement to Teen Vogue. “I would not have agreed to do any consulting work for [Purdue] and I regret that I did,” he said.
Source- Trevor Project CEO Amit Paley Removed From Position After Staff Outcry | Teen Vogue
Amit Paley CEO resignation amid questions about previous McKinsey work.
Amit Paley CEO has resigned as CEO of the Trevor Project, a nonprofit that provides crisis intervention and suicide prevention services to LGBTQ youth, owing to his previous work with consulting firm McKinsey & Co.
Amit Paley CEO spent six years as an associate partner at McKinsey before joining the Trevor Project. During that time, he is claimed to have provided significant advice to Purdue Pharma, the maker of OxyContin, a highly addictive drug that many blame for the escalation of America’s opioid epidemic.
HuffPost reported in July on Paley’s engagement with Purdue, which included attempting to repair the company’s reputation by downplaying the dangers of its products and collaborating with Purdue executives on tactics to increase the company’s product sales, particularly opioids.
Amit Paley CEO apologized for his role in the opioid crisis in a statement to HuffPost at the time, saying, “Seven years ago, when I was a consultant at McKinsey, I was assigned to a project for Purdue.” I would not have accepted to undertake any consulting for that company if I had known what I know today, and I regret that I did.”
The Trevor Project, the world’s largest suicide prevention and mental health organization for LGBTQ youth was recently awarded one of Fast Company’s Brands That Matter for its work as the world’s leading suicide prevention and mental health organization for LGBTQ youth. As the Trevor Project documented earlier this year, consistent prescription drug misuse was related to nearly three times the risks of LGBTQ kids trying suicide.
With Amit Paley’s CEO’s work background revealed, and internal nonprofit complaints of over-scaling with limited resources, he was dismissed from his executive role on November 2. Peggy Rajski, a Trevor Project cofounder, has taken over as interim CEO.
McKinsey’s reputation has recently suffered. The firm has 30,000 global workers, a customer list that includes 90 of the world’s 100 largest firms, and alumni like Alphabet CEO Sundar Pichai and former Facebook COO Sheryl Sandberg. In recent years, investigative reporting such as ProPublica’s “McKinsey Rules” and Walt Bogdanich and Michael Forsythe’s new book When McKinsey Comes to Town have revealed McKinsey’s work with opioid manufacturers, cigarette manufacturers, US Immigration and Customs Enforcement, and autocratic regimes.
Amit Paley CEO did not address his work with McKinsey or the reason for his dismissal in a statement emailed to Fast Company, but he did highlight the Trevor Project’s development and other triumphs during his tenure. Amit Paley CEO went on to say that he is “deeply committed to the organization’s vision.”
Amit Paley CEO- McKinsey & Company (The company in which Amit Paley worked previously)
McKinsey & Company, founded in 1926 by University of Chicago professor James O. McKinsey, is a multinational management consulting firm that provides professional services to enterprises, governments, and other organizations. McKinsey & Company is the largest and oldest of the “Big Three” management consulting firms. The firm primarily focuses on its clients’ finances and operations.
McKinsey expanded into Europe during the 1940s and 1950s under the guidance of Marvin Bower. In the 1960s, McKinsey’s Fred Gluck, Boston Consulting Group’s Bruce Henderson, Bain & Company’s Bill Bain, and Harvard Business School’s Michael Porter launched a campaign to reform corporate culture. McKinsey’s John L. Neuman’s 1975 paper developed the corporate practice of “overhead value analysis,” which contributed to a downsizing trend that eliminated many jobs in middle management.
McKinsey has a very competitive hiring procedure and is often regarded as one of the world’s most selective employers. McKinsey primarily recruits from top business schools and was one of the first management consultancies to hire a limited number of applicants with significant academic degrees and extensive area expertise, as well as business acumen and analytical ability. McKinsey Quarterly is a business magazine published by McKinsey.
McKinsey has been embroiled in serious criticism over its business practices. The corporation has been chastised for its involvement in encouraging OxyContin use during the North American opioid crisis, its collaboration with Enron, and its work for authoritarian regimes such as Saudi Arabia and Russia.
Amit Paley CEO’s Role In The Opioid Crisis
HuffPost previously reported that Amit Paley CEO was a member of a McKinsey consulting team for OxyContin maker Purdue Pharma.
The Trevor Project’s troubled CEO, Amit Paley CEO, was dismissed from the helm of the LGBTQ suicide prevention organization by the group’s board of directors this month after substantial staff dissent against his leadership, the company revealed.
Paley’s dismissal comes only months after HuffPost revealed that while working for the global consulting company McKinsey & Company, Amit Paley CEO had worked with Purdue Pharma, the renowned OxyContin maker. Teen Vogue was the first to report about his departure.
Around the time of HuffPost’s disclosures, Trevor Project personnel were criticizing Paley’s vision for the group, claiming that his emphasis on development was undermining the quality of counseling available to LGBTQ adolescents in crisis.
“Many members of our staff have raised concerns about workplace well-being, professional development, prioritization performance metrics, and resourcing compensation — particularly as they impact our BIPOC, transgender, nonbinary, and disabled team members,” The Trevor Project told HuffPost in a statement. While a comprehensive, independent review of The Trevor Project is being conducted, the Board of Directors elected to make a change in leadership.
According to a letter addressed to The Trevor Project personnel by the current board chair, Julian Moore, the Trevor Project has also hired outside counsel to conduct an investigation into staff allegations. The letter, which HuffPost obtained, did not describe the nature of those allegations.
During Paley’s time at Purdue Pharma, in 2016 and 2017, the opioid epidemic was taking tens of thousands of lives each year, and Purdue Pharma’s reputation was in shambles. Amit Paley CEO was part of a McKinsey team that assisted Purdue in developing a 10-year strategic plan to increase sales of opioids and other Purdue medicines, according to HuffPost.
Paley also helped McKinsey compete to handle data analysis for Purdue and compete for a separate project that involved resuscitating Purdue’s collapsing public reputation.
In 2017, Amit Paley CEO left McKinsey to lead The Trevor Project. His role on McKinsey’s Purdue account remained a secret until this summer when McKinsey published more than a decade’s worth of documents from its work with Purdue as part of a $573 million settlement over McKinsey’s role in the opioid crisis.
“If I knew then what I know now, I would not have agreed to do any consulting for that company, and I regret that I did,” Paley stated this summer in a statement to HuffPost. The chair of the board, Gina Muoz, stated that the board had “full confidence in Amit as CEO of The Trevor Project and stands firmly behind him.”
The Trevor Project staff was allegedly shocked to learn about Paley’s work for Purdue. According to the organization’s own research, there is a correlation between prescription medication usage and an increase in suicide risk among LGBTQ children. According to Teen Vogue, several staff members believed Paley should quit in the aftermath of HuffPost’s story.
Many personnel were already disturbed by Paley’s concept for The Trevor Project: a focus on rapidly scaling up its LGBTQ counseling services, which the staffers claimed was coming at the expense of quality.
In the run-up to Paley’s departure, more than 200 Trevor Project employees signed a statement criticizing the organization’s rapid expansion.
Peggy Rajski, a co-founder, who will apparently serve as interim CEO, with assistance from Muoz.
“It has been an honor of a lifetime to lead The Trevor Project’s life-saving team for over five years,” Paley told HuffPost. During his tenure as CEO, he stated that the organization’s counseling services rose tenfold, became available 24/7, and extended overseas for the first time.
“We grew our team from 50 employees to over 500. The Trevor Project’s vital work is needed now more than ever, and I will always remain deeply committed to the organization’s vision of a world where all LGBTQ young people see a bright future for themselves.”
Amit Paley CEO- Opioid Crisis (In reference to the illegal act by Amit Paley CEO)
The opioid epidemic, also known as the opioid crisis, refers to the significant growth in overuse, misuse/abuse, and overdose mortality caused by the class of medications known as opiates/opioids since the 1990s. It encompasses the serious medical, social, psychological, demographic, and economic implications of these medicines’ medicinal, non-medical, and recreational abuse.
Opioids are a diverse class of moderate to strong painkillers that include oxycodone (commonly known as OxyContin and Percocet), hydrocodone (Vicodin, Norco), and fentanyl, a very strong painkiller that is synthesized to look like other opiates such as opium-derived morphine and heroin. Despite the risk of addiction and overdose, the strength and availability of these chemicals have made them popular as both medicinal treatments and recreational drugs.
Because opioids have sedative effects on the respiratory center of the medulla oblongata, excessive doses can cause respiratory depression, which can lead to respiratory failure and death. Opioids are highly effective for treating acute pain, but there is strong debate over whether they are effective in treating chronic or high-impact intractable pain, as the risks may outweigh the benefits.
LGBT (The Suicide prevention organization associated with Amit Paley CEO)
LGBT is an abbreviation for “lesbian, gay, bisexual, and transgender”. The initialism, as well as some of its popular forms, has been used as an umbrella word encompassing minority sexualities and gender identities since the late 1980s.
LGBT is an abbreviation for LGB, which began to supplant the term homosexual (or gay and lesbian) in reference to the LGBT community in the mid-to-late 1980s. When transgender people are not included, the shorter LGB is still utilized.
It can refer to anyone who is not heterosexual or cisgender, rather than only lesbian, gay, bisexual, or transgender people. LGBTQ adds the letter Q for persons who identify as queer or have doubts about their sexual or gender identity.[6] Another common form, LGBTQ+, adds a plus symbol to denote categories that are not covered in LGBT. There are also more variants of the abbreviation, including LGBTQIA+ (adding intersex and asexual/aromantic) and 2SLGBTQ+ (adding two-spirit). The terms LGBT are not universally accepted by everyone who is supposed to be included in them.
Wrap-Up
A Stepwise Approach for Preventing Suicide by Lethal Poisoning
Suicide is a worldwide issue and the tenth-highest cause of mortality in the United States. Veterans are more prone than the general population to commit suicide. After correcting for population disparities in age and gender, the suicide rate for all US veterans in 2018 was 1.5 times higher than the rate for nonveterans. In light of this imbalance, the US Department of Veterans Affairs (VA) has made suicide prevention one of its top goals. One of the primary goals of the VA’s suicide prevention plan is to restrict access to fatal measures.
Overdoes from opioids can occur for a variety of reasons, including:
- When a person overdoses on an illegal opioid narcotic like heroin or morphine, he or she may overdose on methadone. This can happen if someone takes an excess dose by accident, intentionally misuses a prescription opioid, or mixes opioids with other drugs, such as alcohol, or over-the-counter treatments. When an opioid is used with anxiety drugs, such as Xanax or Valium, an overdose can be lethal.
- When a person abuses an opioid-based pain medicine, either by not taking it as prescribed by their doctor or by taking one prescribed for someone else. Children are especially vulnerable to unintentional overdosing if they take medication that was not prescribed for them.
Preventing Opioid Overdose
Opioid overdose can occur even with prescription opioid pain relievers and medications used in treating SUD such as methadone and buprenorphine. In addition, individuals using naltrexone for MOUD have a reduced tolerance to opioids, and therefore, using the same, or even lower doses of opioids used in the past, can cause life-threatening consequences.
Always follow the instructions you receive with your medication. Ask your practitioner or pharmacist if you have questions or are unsure of how to take your medication.
The following suggestions can assist you or a loved one in avoiding an opioid overdose:
- Take the medication as directed by your doctor.
- Never take more medication or take it more frequently than prescribed. Never combine pain relievers with alcohol, sleeping medications, or illegal substances.
- Never take another person’s drugs.
- Store your medication out of reach of children and pets to avoid accidental intake. Visit the CDC’s Up and Away educational campaign for additional information.
- Unused medication should be disposed of safely. Consult your MOUD practitioner for advice, or for additional information on the safe disposal of unwanted pharmaceuticals, go to the FDA’s unneeded medicine disposal or the DEA’s drug disposal webpages.
Recognizing Opioid Overdose
Opioid overdose is life-threatening and requires immediate emergency attention. Recognizing the signs of opioid overdose is essential to saving lives.
Call 911 immediately if a person exhibits ANY of the following symptoms:
- Their face is extremely pale and/or feels clammy to the touch
- Their body goes limp
- Their fingernails or lips have a purple or blue color
- They start vomiting or making gurgling noises
- They cannot be awakened or are unable to speak
- Their breathing or heartbeat slows or stops
Opioid Overdose Treatment
If you suspect someone is suffering from an opioid overdose, do the following steps right away to preserve their life:
- Call 911
- Begin CPR (best administered by someone with training) if the individual has stopped breathing or if breathing is very weak. If naloxone is available, treat the person with it to reverse opioid overdose.
- Family members, caregivers, and others who spend time with opioid users must be trained to recognize the indications of an overdose and provide life-saving care until emergency medical assistance arrives. Individuals suffering from an opioid overdose will be unable to treat themselves. Naloxone is an opioid overdose prevention medicine licensed by the Food and Drug Administration (FDA). Consult your doctor about how to proceed.
